Company Search:
Advanced Search
Sponsored Links
Antisense Therapeutics Limited Company Snapshot
Antisense Therapeutics Limited operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Antisense Therapeutics Limited with three other companies in this sector in Australia: Dimerix Ltd (2019 sales of 18,108.00 Australian Dollars [US$12,293.34 ] ), Amplia Therapeutics Ltd (50,474.00 Australian Dollars [US$34,266.29 ] ), and Ultracharge Ltd (83,994.00 Australian Dollars [US$57,022.69 ] ).

Sales Analysis. Sales increased substantially in 2019: Antisense Therapeutics Limited reported sales of A$66,168.00 (US$44.92 thousand) for the fiscal year ending June of 2019. This represents an increase of 158.9% versus 2018, when the company's sales were A$25,553.00 . Despite this increase, sales are still well below the level achieved in 2017, when Antisense Therapeutics Limited reported sales of A$140,169.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Antisense Therapeutics Limited
  Stock Performance Chart for Antisense Therapeutics Limited
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): .09
(Figures in Australian Dollars)
1 Week -3.1%   13 Weeks 88.0%  
4 Weeks 108.9%   52 Weeks 422.2%  
Antisense Therapeutics Limited Key Data:
  Ticker: ANP Country: Australia
  Exchanges: Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 66,168
(Year Ending Jan 2020).
Employees: 8
  Currency: Australian Dollars Market Cap: 39,489,728
  Fiscal Yr Ends: June Shares Outstanding: 420,103,487
  Share Type: Ordinary Closely Held Shares: 94,004,362
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.